Drug Resistant Clinical Trials

1 recruiting

About Drug Resistant Clinical Trials

Looking for clinical trials for Drug Resistant? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Drug Resistant trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Drug Resistant clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 46 trials

Recruiting
Phase 1Phase 2

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

EpilepsyDrug Resistant EpilepsySeizures, Focal
NaviFUS Corporation8 enrolled3 locationsNCT06388707
Recruiting
Not Applicable

A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

EpilepsyDrug Resistant EpilepsyEpilepsy, Temporal Lobe+1 more
NaviFUS Corporation16 enrolled1 locationNCT06492720
Recruiting
Early Phase 1

The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy

EpilepsyDrug Resistant
Xuanwu Hospital, Beijing5 enrolled1 locationNCT07095933
Recruiting
Early Phase 1

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

IgA Nephropathy (IgAN)Autoimmune DiseasesSystemic Sclerosis (SSc)+3 more
The Children's Hospital of Zhejiang University School of Medicine15 enrolled1 locationNCT07507201
Recruiting

Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients

Multi Drug Resistant Organisms
Valeriu Gheorghita400 enrolled1 locationNCT07134270
Recruiting
Not Applicable

Infrared Photobiomodulation in Humans With Epilepsy

Drug Resistant Epilepsy
Beth Israel Deaconess Medical Center13 enrolled1 locationNCT07145489
Recruiting
Phase 1

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease

IgA Nephropathy (IgAN)Autoimmune DiseasesSystemic Sclerosis (SSc)+3 more
The Children's Hospital of Zhejiang University School of Medicine15 enrolled1 locationNCT07305116
Recruiting
Phase 2

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

TuberculosisMultidrug Resistant Pulmonary Tuberculosis
WestVac Biopharma Co., Ltd.60 enrolled7 locationsNCT07170800
Recruiting

Impact of Epileptic Discharge on the Structural Connectivity of the Developing Brain

PediatricsDrug Resistant EpilepsyEpilepsies, Focal
Fondation Ophtalmologique Adolphe de Rothschild82 enrolled1 locationNCT03268824
Recruiting
Not Applicable

Efficacy of Personnalized Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epileptic

EpilepsyDrug Resistant Epilepsy
Assistance Publique Hopitaux De Marseille60 enrolled7 locationsNCT06334952
Recruiting
Early Phase 1

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine36 enrolled1 locationNCT06792799
Recruiting
Phase 2

Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)

Multi-Drug Resistant Organism Colonization
Emory University60 enrolled4 locationsNCT06321536
Recruiting
Phase 2

PMT for MDRO Decolonization

Enterobacteriaceae InfectionsMultidrug Resistant Bacterial Infection
University of Pennsylvania150 enrolled3 locationsNCT05632315
Recruiting
Not Applicable

Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

Drug Resistant Tuberculosis
Johns Hopkins University2,944 enrolled5 locationsNCT05671718
Recruiting
Not Applicable

Goals for Epilepsy Clinic Visits Trial

Drug Resistant Epilepsy
University of Michigan152 enrolled1 locationNCT05928598
Recruiting
Not Applicable

Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial

Drug Resistant Epilepsy
Brigham and Women's Hospital10 enrolled1 locationNCT03868293
Recruiting
Not Applicable

Focused Ultrasound for Drug-resistant Epilepsy

Drug Resistant EpilepsyDrug Refractory EpilepsyFocused Ultrasound+2 more
Taipei Veterans General Hospital, Taiwan20 enrolled1 locationNCT06292494
Recruiting
Phase 1

Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS

CAR-T Cell TherapyMulti-Drug Resistant Nephrotic Syndrome
The Children's Hospital of Zhejiang University School of Medicine18 enrolled1 locationNCT06553898
Recruiting

Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients

Autism Spectrum DisorderDrug Resistant EpilepsyChronic Migraine+1 more
Danone Nutricia SpA Società Benefit100 enrolled3 locationsNCT06309251
Recruiting
Phase 2

The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy

Drug Resistant Epilepsy
Madeline Fields8 enrolled1 locationNCT05019885